Enterprise Value to EBITDA Multiple ratio Analysis of Arbutus Biopharma Corp - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-5.89
Period Ending - Dec-22
Very Poor EV to EBITDA
-7.71
Growth
23.62 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-6.41
EV to EBITDA Analysis of Arbutus Biopharma Corp
| EV to EBITDA Ratio of ABUS rose handsomely by 23.62 % this year. |
| EV to EBITDA Ratio with value of -0.988 was highest in Year Dec-19 in last Five Years. |
| EV to EBITDA Ratio with value of -7.71 was lowest in Year Dec-22 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -5.89 is lower than Average EV to EBITDA of -4.31 in last five years. |
Other EV to EBITDA Related Info of ABUS that may interest you.
Arbutus Biopharma Corp Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ABUS | 3.36 | 3.32 | 1.20 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Arbutus Biopharma Corp
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| EV to EBITDA | -5.89 | -7.71 | -3.46 | -3.51 | -0.988 | -2.53 | -1.42 |
| Change | 23.62 % | -122.56 % | 1.45 % | -255.48 % | 60.87 % | -77.50 % | -287.29 % |
FY Chart of Enterprise Value to EBITDA Multiple of Arbutus Biopharma Corp
Note : All Data Generated at the End of Trading Hours (EOD Data)